1 | Post Covid-19 symptoms among Covid-19 patients with comorbidities and non-comorbidities in Peninsular Malaysia | 719 |
2 | Edible bird nest as a potential cognitive enhancer | 658 |
3 | Is sugar or fat worse? | 611 |
4 | Tau protein as a biomarker for asphyxia: a possible forensic tool? | 549 |
5 | C-Abl inhibition; a novel therapeutic target for Parkinson’s disease | 461 |
6 | The promise of the Zebrafish model for Parkinson’s disease: today’s science and tomorrow’s treatment | 445 |
7 | Depression following major life transitions in women: a review and theory | 436 |
8 | Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease | 427 |
9 | Pharmacotherapy of alzheimer’s disease: seeking clarity in a time of uncertainty | 427 |
10 | Burnout in academia the physiological effects of contagion and isolation go beyond fear of contracting the Covid-19 virus | 423 |
11 | Tubulin and tau: Possible targets for diagnosis of Parkinson’s and Alzheimer’s diseases | 415 |
12 | siRNA blocking of mammalian target of rapamycin (mTOR) attenuates pathology in annonacin-induced tauopathy in mice | 412 |
13 | Mechanisms of disordered neurodegenerative function: concepts and facts about the different roles of the protein kinase RNA-like endoplasmic reticulum kinase (PERK) | 402 |
14 | Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model | 400 |
15 | Editorial: biomarkers in neurology | 398 |
16 | Interactions between cannabis and schizophrenia
in humans and rodents | 394 |
17 | Neuroprotective effect of edible bird’s nest in chronic cerebral hypoperfusion induced neurodegeneration in rats | 387 |
18 | Thyroxine (T4) transfer from blood to cerebrospinal fluid in sheep isolated perfused choroid plexus: role of
multidrug resistance-associated Proteins and Organic anion
Transporting Polypeptides | 387 |
19 | Oxidative stress status and neuroprotection of tocotrienols in chronic cerebral hypoperfusion-induced neurodegeneration rat animal model | 376 |
20 | FOXRED1 silencing in mice: a possible animal model for leigh syndrome. | 376 |
21 | Integrated neural technologies: solutions beyond tomorrow | 374 |
22 | Light-Emitting Diode (LED) therapy attenuates neurotoxicity of methanol-induced memory impairment and apoptosis in the hippocampus | 371 |
23 | Animal model for leigh syndrome | 371 |
24 | Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls | 367 |
25 | Genetic underpinnings in Alzheimer’s disease –
A review | 348 |
26 | Hormones in experimental autoimmune encephalomyelitis (EAE) animal models | 347 |
27 | Biomarkers in neurology | 346 |
28 | Biomarkers in AD: current state of translational research | 337 |
29 | Editorial: contribution of translational animal models to the systems biology of neurodegenerative disorders | 334 |
30 | Atypical antipsychotic lumateperone effects on the adrenal gland with possible beneficial effect of quercetin co-administration | 324 |